Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Novartis
Moodys
Healthtrust
Merck
Chubb
Chinese Patent Office
Baxter
Johnson and Johnson
Queensland Health

Generated: February 22, 2018

DrugPatentWatch Database Preview

Lundbeck Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for LUNDBECK PHARMS LLC, and when can generic versions of LUNDBECK PHARMS LLC drugs launch?

LUNDBECK PHARMS LLC has five approved drugs.

There are six US patents protecting LUNDBECK PHARMS LLC drugs.

There are fifty-four patent family members on LUNDBECK PHARMS LLC drugs in nineteen countries.

Summary for Lundbeck Pharms Llc
International Patents:54
US Patents:6
Tradenames:3
Ingredients:3
NDAs:5

Drugs and US Patents for Lundbeck Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Pharms Llc SABRIL vigabatrin FOR SOLUTION;ORAL 022006-001 Aug 21, 2009 AA RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc SABRIL vigabatrin TABLET;ORAL 020427-001 Aug 21, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;IV (INFUSION) 206030-001 Oct 7, 2016 RX Yes Yes 9,493,582 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;IV (INFUSION) 206030-001 Oct 7, 2016 RX Yes Yes 7,635,773 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-002 Oct 21, 2011 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc ONFI clobazam TABLET;ORAL 202067-003 Oct 21, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;IV (INFUSION) 206030-001 Oct 7, 2016 RX Yes Yes 8,410,077 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;IV (INFUSION) 206030-001 Oct 7, 2016 RX Yes Yes 9,629,797 ➤ Try a Free Trial ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;IV (INFUSION) 206030-001 Oct 7, 2016 RX Yes Yes 9,750,822 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;IV (INFUSION) 206030-001 Oct 7, 2016 RX Yes Yes 9,770,407 ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Lundbeck Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,200,088 Sulfoalkyl ether cyclodextrin compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Lundbeck Pharms Llc Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cantor Fitzgerald
Fuji
Queensland Health
Medtronic
Deloitte
Daiichi Sankyo
Cipla
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot